dc.contributor.author | EGELI, U | |
dc.contributor.author | ERDOGAN, G | |
dc.date.accessioned | 2021-03-04T14:00:59Z | |
dc.date.available | 2021-03-04T14:00:59Z | |
dc.date.issued | 1991 | |
dc.identifier.citation | EGELI U., ERDOGAN G., "THE CLASTOGENIC EFFECT OF PYRIMETHAMINE (DARAPRIM) ON HUMAN-CHROMOSOMES IN LYMPHOCYTE-CULTURES", CELL BIOLOGY AND TOXICOLOGY, cilt.7, sa.4, ss.347-356, 1991 | |
dc.identifier.issn | 0742-2091 | |
dc.identifier.other | av_7f526582-6854-4f7b-a88f-17fe6a6b726a | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/86902 | |
dc.identifier.uri | https://doi.org/10.1007/bf00124070 | |
dc.description.abstract | In this study the clastogenic effect of pyrimethamine (Daraprim), a folic acid antagonist used for the treatment of toxoplasmosis and malaria on human chromosomes, was investigated. Pyrimethamine was added to in vitro lymphocyte cultures at six different concentrations: 0.05 (normal therapeutic dose), 0.1, 0.2, 0.4, 0.8, and 1.6 mg/ml. No proliferation was observed in any of the cultures containing 1.6 mg/ml pyrimethamine. The results of the cytogenetic evaluations show that the frequency of breaks and gaps increase significantly in dose-dependent manner. Thus, pyrimethamine has a clastogenic effect on human chromosomes. | |
dc.language.iso | eng | |
dc.subject | Histoloji-Embriyoloji | |
dc.subject | Eczacılık | |
dc.subject | Meslek Bilimleri | |
dc.subject | Farmasötik Toksikoloji | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Temel Bilimler | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Tıp | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | TOKSİKOLOJİ | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | HÜCRE BİYOLOJİSİ | |
dc.title | THE CLASTOGENIC EFFECT OF PYRIMETHAMINE (DARAPRIM) ON HUMAN-CHROMOSOMES IN LYMPHOCYTE-CULTURES | |
dc.type | Makale | |
dc.relation.journal | CELL BIOLOGY AND TOXICOLOGY | |
dc.contributor.department | , , | |
dc.identifier.volume | 7 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 347 | |
dc.identifier.endpage | 356 | |
dc.contributor.firstauthorID | 113049 | |